Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction.

Kamon D, Okura H, Okamura A, Nakada Y, Hashimoto Y, Sugawara Y, Ueda T, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Kawakami R, Saito Y.

Circ J. 2019 May 24;83(6):1324-1329. doi: 10.1253/circj.CJ-18-1195. Epub 2019 Apr 20.

2.

Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.

Ueda T, Kawakami R, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y.

Circ J. 2015;79(6):1307-14. doi: 10.1253/circj.CJ-14-1203. Epub 2015 Mar 3.

3.

Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.

Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM.

PLoS One. 2018 Jun 13;13(6):e0198144. doi: 10.1371/journal.pone.0198144. eCollection 2018.

4.

Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.

Muhlestein JB, May HT, Bair TL, Prescott MF, Horne BD, White R, Anderson JL.

Am J Cardiol. 2010 Sep 15;106(6):764-9. doi: 10.1016/j.amjcard.2010.04.040. Epub 2010 Aug 1.

PMID:
20816114
5.

Vitamin D and prognosis in acute myocardial infarction.

Ng LL, Sandhu JK, Squire IB, Davies JE, Jones DJ.

Int J Cardiol. 2013 Oct 3;168(3):2341-6. doi: 10.1016/j.ijcard.2013.01.030. Epub 2013 Feb 13.

PMID:
23415169
6.

Prognostic Value of Plasma Soluble Corin in Patients With Acute Myocardial Infarction.

Zhou X, Chen J, Zhang Q, Shao J, Du K, Xu X, Kong Y.

J Am Coll Cardiol. 2016 May 3;67(17):2008-14. doi: 10.1016/j.jacc.2016.02.035.

7.

Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus.

Joo HJ, Cho SA, Hong SJ, Hur SH, Bae JH, Choi DJ, Ahn YK, Park JS, Choi RK, Choi D, Kim JH, Han KR, Park HS, Choi SY, Yoon JH, Kwon HC, Rha SW, Hwang KK, Jung KT, Oh SK, Lee JH, Shin ES, Kim KS, Kim HS, Lim DS.

Lipids Health Dis. 2016 Nov 18;15(1):197.

8.

Proenkephalin and prognosis after acute myocardial infarction.

Ng LL, Sandhu JK, Narayan H, Quinn PA, Squire IB, Davies JE, Bergmann A, Maisel A, Jones DJ.

J Am Coll Cardiol. 2014 Jan 28;63(3):280-9. doi: 10.1016/j.jacc.2013.09.037. Epub 2013 Oct 16.

9.

Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT).

Masson S, Solomon S, Angelici L, Latini R, Anand IS, Prescott M, Maggioni AP, Tognoni G, Cohn JN; Val-Heft Investigators.

J Card Fail. 2010 Dec;16(12):964-70. doi: 10.1016/j.cardfail.2010.06.417.

PMID:
21111986
10.

Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).

Mentz RJ, Broderick S, Shaw LK, Fiuzat M, O'Connor CM.

J Am Coll Cardiol. 2014 Jan 28;63(3):251-8. doi: 10.1016/j.jacc.2013.09.039. Epub 2013 Oct 23.

11.

Prognostic value of plasma renin activity in heart failure.

Vergaro G, Emdin M, Iervasi A, Zyw L, Gabutti A, Poletti R, Mammini C, Giannoni A, Fontana M, Passino C.

Am J Cardiol. 2011 Jul 15;108(2):246-51. doi: 10.1016/j.amjcard.2011.03.034. Epub 2011 May 3.

PMID:
21545993
12.

Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

Sever PS, Chang CL, Prescott MF, Gupta A, Poulter NR, Whitehouse A, Scanlon M.

Eur Heart J. 2012 Dec;33(23):2970-9. doi: 10.1093/eurheartj/ehs241. Epub 2012 Aug 31.

PMID:
22942337
13.

Plasma cortisol and prognosis of patients with acute myocardial infarction.

Jutla SK, Yuyun MF, Quinn PA, Ng LL.

J Cardiovasc Med (Hagerstown). 2014 Jan;15(1):33-41. doi: 10.2459/JCM.0b013e328364100b.

PMID:
24500236
14.

Circulating Serpina3 levels predict the major adverse cardiac events in patients with myocardial infarction.

Zhao L, Zheng M, Guo Z, Li K, Liu Y, Chen M, Yang X.

Int J Cardiol. 2019 Aug 15. pii: S0167-5273(19)33203-6. doi: 10.1016/j.ijcard.2019.08.034. [Epub ahead of print]

PMID:
31439424
15.

Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction.

Lorgis L, Jourda F, Hachet O, Zeller M, Gudjoncik A, Dentan G, Stamboul K, Guenancia C, Mock L, Cottin Y; RICO Survey Working Group.

Heart Lung. 2013 Sep-Oct;42(5):326-31. doi: 10.1016/j.hrtlng.2013.05.005. Epub 2013 Jul 11.

PMID:
23850293
16.

Potential role of plasma myeloperoxidase level in predicting long-term outcome of acute myocardial infarction.

Kaya MG, Yalcin R, Okyay K, Poyraz F, Bayraktar N, Pasaoglu H, Boyaci B, Cengel A.

Tex Heart Inst J. 2012;39(4):500-6.

17.

Prognostic impact of unrecognized myocardial scar in the non-culprit territories by cardiac magnetic resonance imaging in patients with acute myocardial infarction.

Omori T, Kurita T, Dohi K, Takasaki A, Nakata T, Nakamori S, Fujimoto N, Kitagawa K, Hoshino K, Tanigawa T, Sakuma H, Ito M.

Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):108-116. doi: 10.1093/ehjci/jex194. Erratum in: Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):122.

PMID:
28950314
18.

Admission Heart Rate Is a Determinant of Effectiveness of Beta-Blockers in Acute Myocardial Infarction Patients.

Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Ohshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET Investigators.

Circ J. 2019 Apr 25;83(5):1054-1063. doi: 10.1253/circj.CJ-18-0995. Epub 2019 Mar 30.

19.

Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.

Verma S, Gupta M, Holmes DT, Xu L, Teoh H, Gupta S, Yusuf S, Lonn EM.

Eur Heart J. 2011 Sep;32(17):2135-42. doi: 10.1093/eurheartj/ehr066. Epub 2011 Mar 17.

PMID:
21415069
20.

Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Lindberg S, Pedersen SH, Mogelvang R, Jensen JS, Flyvbjerg A, Galatius S, Magnusson NE.

J Am Coll Cardiol. 2012 Jul 24;60(4):339-45. doi: 10.1016/j.jacc.2012.04.017.

Supplemental Content

Support Center